NX 211: Began Phase I testing

NeXstar Pharmaceuticals Inc. (NXTR), Boulder, Colo. Product: NX 211 Business: Cancer Therapeutic category: Cell proliferation Target: Topoisomerase I Description: Liposomal form of lurtotecan topoiso...